MAHSHID TOGHANIAN: Open Payments
NPI 1710524533 · PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 32 payments from 13 companies in 2025. Trend: 2023 $1,396 · 2024 $1,798 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $161 |
| Amgen Inc. | 4 | $89 |
| Cumberland Pharmaceuticals, Inc. | 1 | $79 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Novo Nordisk Inc | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Ardelyx, Inc. | 3 | $61 |
| Inspire Medical Systems, Inc. | 2 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
Products named: REXULTI, KRISTALOSE, Auvelity, TRELEGY ELLIPTA, OTEZLA, IBSRELA, FARXIGA, INSPIRE.
Industry payments across NY — which companies pay providers there.
